Skip to content

The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06879808
Acronym
Color Therapy
Enrollment
60
Registered
2025-03-17
Start date
2024-04-01
Completion date
2025-02-01
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Color Therapy, Hemodialysis

Keywords

Anxiety, Color Therapy, Depression, Hemodialysis, Nursing, Quality of Life, Stress

Brief summary

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

Detailed description

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

Interventions

In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.

Sponsors

Erzincan Binali Yildirim Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Intervention model description

Randomization; participants were divided into two groups by using simple random numbers table, and then the first group which was drawn by lot method was named as the experimental group.

Eligibility

Sex/Gender
ALL
Age
18 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

* Be on hemodialysis treatment for at least 6 months, * No sleeping pills or sedative medication, * No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness, * The patient or someone living in the same household with the patient is literate, * Patients have no vision problems, * Patients must be 18 years of age or older.

Exclusion criteria

* Being on hemodialysis treatment for less than 6 months, * Taking sleeping pills or sedative medication, * Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided, * Illiteracy of the patient and relatives, * Patients have vision problems, * Refusing to participate in the research, * Under 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Depression Anxiety Stress-21 scale (DASS-21)8 weekThe 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 not applicable to me, 1 somewhat applicable to me, 2 generally applicable to me, and 3 completely applicable to me.
Short Form-12 (SF-12) Quality of Life Scale8 weekWare et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026